Is Xeris Biopharma Holdings Inc (NASDAQ: XERS) Proving The Doubters Wrong?

BlackRock Fund Advisors has recently announced that it has increased stake in Xeris Biopharma Holdings Inc (NASDAQ:XERS) by 0.67%. After grabbing 8.4 million shares, the institutional investor is now in possession of 56076.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 6.08% having worth around $15.63 million. Moreover, […]

Is Xeris Biopharma Holdings Inc (NASDAQ: XERS) Proving The Doubters Wrong?

BlackRock Fund Advisors has recently announced that it has increased stake in Xeris Biopharma Holdings Inc (NASDAQ:XERS) by 0.67%. After grabbing 8.4 million shares, the institutional investor is now in possession of 56076.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 6.08% having worth around $15.63 million. Moreover, […]